Stay updated on SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial

Sign up to get notified when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added MRD-negative remission rate endpoints for infants and older infants, and expanded exploratory objectives to include PK analyses of calaspargase pegol within the revumenib-plus-chemotherapy regimen. Updated regimen descriptions and cycle structure, and removed certain MRD and PK items from the previous version.
    Difference
    0.8%
    Check dated 2026-04-03T18:37:14.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page. The change appears to be a global versioning update with no visible edits to study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-03-20T04:56:37.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-05T19:00:43.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.4.1 to v3.4.2; no visible changes to study content or structure. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T02:53:48.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The change is a minor version update from v3.4.0 to v3.4.1 with no impact on study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T22:58:44.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page now shows a Show glossary option, includes a 'Last Update Submitted that Met QC Criteria' label, a 'No FEAR Act Data' notice, and a new 'Revision: v3.4.0' footer. These UI/metadata updates do not modify the study data or core content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T20:04:21.000Z thumbnail image

Stay in the know with updates to SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.